This Data is provided by Genesis Investment Management, LLP (“Genesis”) which is authorised and regulated by the Financial Conduct Authority (“FCA”). Registered office: 21 Grosvenor Place, London SW1X 7HU. Registered in England, number OC306866. A member of the Investment Association.
All investments and services mentioned are directed at persons who are Professional Clients or Eligible Counterparties as defined by the FCA and to persons falling within the Financial Services and Markets Act 2000 (Promotion of Collective Investment Schemes) (Exemptions) Order 2001 and should not be relied upon by Retail Clients. It does not constitute investment advice and should not be used as the basis of any investment decision, nor should it be treated as a recommendation for any investment. Under no circumstances should any part of this information be construed as an offering or solicitation. Subscriptions to shares of the Fund can only be made on the basis of the current prospectus, the relevant Key Investor Information Document, accompanied by the latest available audited annual report and the latest semi-annual report if published thereafter.
Past performance should not be relied upon as a guide to future performance, which is not guaranteed. The value of investments can go down as well as up and there is no guarantee that you will get back the amount originally invested. Your investment should be viewed as long term. Genesis invests in emerging markets which tend to be more volatile than more established stock markets and therefore your investment is at greater risk. You should be aware that currency movements can affect the value of your investment. Other risk factors such as political and economic conditions should also be considered.
This data has been prepared by Genesis on the basis of information and sources believed to be reliable. This may not be reproduced in whole or in part without the prior consent of Genesis. Other statistics in this document are from a variety of publicly available information obtained through Genesis’ research.